Log in

Relevant bibliographies by topics / Boston City Hospital. Harvard Medical Unit

Contents

Journal articles
Books
Book chapters

Academic literature on the topic 'Boston City Hospital. Harvard Medical Unit'

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Boston City Hospital. Harvard Medical Unit.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Boston City Hospital. Harvard Medical Unit"

1

Stüve, Olaf. "The Cradle of American Neurology: The Harvard Neurological Unit at the Boston City Hospital." Archives of Neurology 69, no. 10 (October 1, 2012): 1378. http://dx.doi.org/10.1001/archneurol.2012.1822.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Alexeevich, Andreev Alexander, and Anton Petrovich Ostroushko. "Joseph Edward MURRAY - American surgeon-transplant surgeon, academician of the National Academy of Sciences of the United States (to the 100th of birthday)." Journal of Experimental and Clinical Surgery 12, no. 1 (March 2, 2019): 81. http://dx.doi.org/10.18499/2070-478x-2019-12-1-81-81.

Full text

Abstract:

Joseph Murray was born in 1919 in the USA. He graduated from the College of the Holy Cross and Harvard University Medical School. He developed his own method of kidney transplantation, proposed to reduce the risk of immune rejection of the organ by performing closely related transplants. In 1954, D. Murray completed the first successful kidney transplant in the world from a twin brother, in 1959 from an unrelated donor, in 1962 from a deceased donor. In 1971, Murray returned to the study of plastic surgery, being the chief plastic surgeon at the Children's Hospital of Boston from 1972 to 1985. In 1986, he left the surgical practice, having the honorary title of professor at Harvard University Medical School. In 1990, Joseph Murray, along with Edward Thomas was awarded the Nobel Prize in Medicine. In the same year, Joseph Murray was admitted to the Pontifical Academy of Sciences, in 1993 - the National Academy of Sciences of the USA. Joseph Edward Murray died in 2012 in the city of Boston.

APA, Harvard, Vancouver, ISO, and other styles

3

Fagan, Karen A., Kamal K. Mubarak, Zeenat Safdar, Aaron Waxman, and Roham T. Zamanian. "Expanded Use of PAH Medications." Advances in Pulmonary Hypertension 7, no. 1 (January 1, 2008): 249–54. http://dx.doi.org/10.21693/1933-088x-7.1.249.

Full text

Abstract:

This discussion was moderated by Karen A. Fagan, MD, Professor and Director, Division of Pulmonary Medicine, University of South Alabama College of Medicine, Mobile, Alabama. Panel members included Kamal K. Mubarak, MD, Assistant Professor of Medicine, Director, Pulmonary Hypertension Clinic, Wayne State University, Detroit, Michigan; Zeenat Safdar, MD, Assistant Professor of Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas; Aaron Waxman, MD, PhD, Associate Professor of Medicine, Harvard Medical School, Director, Pulmonary Vascular Disease Program and Pulmonary Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts; and Roham T. Zamanian, MD, Assistant Professor of Medicine, Director, Adult Pulmonary Hypertension Clinical Service, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California.

APA, Harvard, Vancouver, ISO, and other styles

4

Mora, J. Rodrigo. "Bone marrow precursors require β7 integrins to give rise to intestinal mononuclear phagocytes with tolerogenic potential (P3290)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 136.27. http://dx.doi.org/10.4049/jimmunol.190.supp.136.27.

Full text

Abstract:

Abstract Eduardo J. Villablanca 1, Jaime De Calisto 1, Patricia Torregrosa Paredes 1, 2, Barbara Cassani 1, Susanne Gabrielsson 2 & J. Rodrigo Mora 1 1 Gastrointestinal Unit, Massachusetts General Hospital & Harvard Medical School, Boston, MA; 2 Translational Immunology Unit, Karolinska Institutet, Stockholm, Sweden Intestinal mononuclear phagocytes, including dendritic cells (DC) and macrophages (MF), develop from at least two different bone marrow (BM) precursors. CD103- MF derive from lineage negative (Lin-) Ly6Chigh monocytes, whereas CD103+ DC, which metabolize vitamin A into all-trans retinoic acid (RA), derive from Lin-Ly6Clow BM precursors. However, how mononuclear phagocytes precursors are recruited to the intestinal mucosa remains unknown. Here, we show that BM Lin-Ly6Clow cells require β7 integrins to reconstitute intestinal mononuclear phagocytes and to give rise to RA-producing mesenteric lymph node DC. Interestingly, the BM contains a distinct population of α4β7+ Lin-Ly6Clow cells, which was markedly reduced in vitamin A-depleted mice. Importantly, mice lacking β7 integrins in the CD11c+ compartment showed decreased generation of antigen-specific regulatory T cells and were impaired in developing oral tolerance. Thus, BM progenitors require α4β7 to give rise to intestinal mononuclear phagocytes with tolerogenic potential.

APA, Harvard, Vancouver, ISO, and other styles

5

Kheiri, Babikir, Ahmed Abdalla, Mohamed Osman, Tarek Haykal, Sai Chintalapati, James Cranford, Sahar Ahmed, Mustafa Hassan, Ghassan Bachuwa, and Deepak L. Bhatt. "Restrictive Versus Liberal Red Blood Cell Transfusion for Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Blood 132, Supplement 1 (November 29, 2018): 3821. http://dx.doi.org/10.1182/blood-2018-99-111993.

Full text

Abstract:

Abstract Introduction:Patients undergoing cardiac surgery are among the most common recipients of allogenic red blood cell (RBC) transfusions. However, whether restrictive RBC transfusion strategies for cardiac surgery achieve a similar clinical outcome in comparison with liberal strategies remains unclear. Methods:We searched PubMed, Embase, the Cochrane Collaboration Central Register of Controlled Trials, and conference proceedings from inception to December 2017 for all randomized trials (RCTs). The primary outcome was mortality. Secondary outcomes were stroke, respiratory morbidity, renal morbidity, infections, myocardial infarction (MI), cardiac arrhythmia, gut morbidity, reoperation, intensive care unit (ICU) length of stay (hours), and hospital length of stay (days). We calculated the risk ratios (RR) and weighted mean difference (MD) for the clinical outcomes using a random-effects model. Results:We included 9 RCTs with a total of 9,005 patients. There was no significant difference in mortality between groups (RR 1.03; 95% CI 0.74-1.45; P=0.86). In addition, there were no significant differences between groups in the clinical outcomes of infections (RR 1.09; 95% CI 0.94-1.26; P=0.26), stroke (RR 0.98; 95% CI 0.72-1.35; P=0.91), respiratory morbidity (RR 1.05; 95% CI 0.89-1.24; P=0.58), renal morbidity (RR 1.02; 95% CI 0.94-1.09; P=0.68), myocardial infarction (RR 1.00; 95% CI 0.80-1.24; P=0.99), cardiac arrhythmia (RR 1.05; 95% CI 0.88-1.26; P=0.56), gastrointestinal morbidity (RR 1.93; 95% CI 0.81-4.63; P=0.14), or reoperation (RR 0.90; 95% CI 0.67-1.20; P=0.46). There was a significant difference in the intensive care unit length of stay (hours) (MD 4.29; 95% CI: 2.19-6.39, P<0.01) favoring the liberal group. However, there was no significant difference in the hospital length of stay (days) (MD 0.15; 95% CI -0.18-0.48; P=0.38). Conclusion:This meta-analysis showed that restrictive strategies for RBC transfusion are as safe as liberal strategies in patients undergoing cardiac surgery. Key points: Restrictive strategies for red blood cell transfusion are as safe as liberal approaches in patients undergoing cardiac surgery. Longer duration of stay in the intensive care unit is more common in patients managed with a restrictive transfusion approach. However, the overall hospital length of stay appeared to be similar between both groups. Further studies are needed to ascertain threshold triggers for RBC transfusion. Figure. Figure. Disclosures Hassan: abott: Other: grant. Bhatt:American Heart Association Quality Oversight Committee: Other: chair; Boston VA Research Institute, Society of Cardiovascular Patient Care, TobeSof: Membership on an entity's Board of Directors or advisory committees; Medscape Cardiology: Consultancy; Regado Biosciences: Consultancy; Elsevier Practice Update Cardiology: Consultancy, trustee; cardax: Consultancy; Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, The Medicines: Research Funding; Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Cleveland Clinic, Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, Population: Other: Data monitoring committee; American College of Cardiology; Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda.: Other: trustee; ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim), Belvoir Publications (Editor in Chief, Harvard Heart Letter),: Other: board member; American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org: Honoraria.

APA, Harvard, Vancouver, ISO, and other styles

6

Londoño, Irene, Vladimir Marshansky, Sylvain Bourgoin, Patrick Vinay, and Moïse Bendayan. "Expression and distribution of adenosine diphosphate-ribosylation factors in the rat kidney111Present address is: Renal Unit & Program in Membrane Biology, Massachusetts General Hospital, Harvard Medical School, 149, 13th Street, 8th Floor, Boston, MA, 02129, USA." Kidney International 55, no. 4 (April 1999): 1407–16. http://dx.doi.org/10.1046/j.1523-1755.1999.00365.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Veal, Donna F. "Association of Intravenous Lipid Emulsion and Coagulase-Negative Staphylococcal Bacteremia in Neonatal Intensive Care Units JONATHAN FREEMAN,* §** M.D., SC.D., DONALD A. GOLDMANN, M.D., ∥ NANCY E. SMITH, M.S.,§ DAVID G. SIDEBOTTOM, M.D.,∥ MICHAEL F. EPSTEIN,†¶ M.D., RICHARD PLAT, M.D., M.S.*‡ Department of Medicine,* Department of Newborn Medicine,† and Infection Control Unit,‡ Brigham and Women's Hospital, Boston, Massachusetts; Brockton/West Roxbury Veterans Affair Medical Center, West Roxbury, Massachusetts;§ Division of Infectious Diseases and Infection Control Program ∥ and Division of Newborn Medicine, ¶ Children's Hospital and Harvard Medical School, Boston; and Department of Epidemiology, Harvard School of Public Health, Boston." Nutrition in Clinical Practice 6, no. 1 (February 1991): 27–28. http://dx.doi.org/10.1177/088453369100600108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Confino, Edmond, Richard H. Demir, Jan Friberg, and Norbert Gleicher. "Does cyclic human chorionic gonadotropin secretion indicate embryo loss in in vitro fertilization?*†‡*The International Collaborators for this study were Benjamin G. Brackett, M.D., Ph.D., The University of Georgia College of Veterinary Medicine, Atlanta, Georgia, USA, Jairo Garcia, M.D., Suheil Muasher, M.D., Anibal A. Acosta, M.D., Mason C. Andrews, M.D., Gary Hodgen, Ph.D., Zev Rosenwaks, M.D., Georgeanna Seegar Jones, M.D., Howard W. Jones, Jr., M.D., Eastern Virginia Medical School, Norfolk, Virginia, USA, Robert H. Glass, M.D., Mary C. Martin, M.D., Pramila Dandekar, M.SC., University of California, San Francisco, California, USA, Vesselko Grizelj, M.D., Ph.D., University Medical School of Zagreb, Zagreb, Yugoslavia, George Henry, M.D., Jon Van Blerkom, M.D., Barbara J. Corn, R.N., Reproductive Genetics, In Vitro, P.C., Denver, Colorado, USA, Aarne Koskimies, M.D., Markku Seppala, M.D., Helsinki University Central Hospital, Helsinki, Finland, David Magyar, M.D., Robert J. Sokol, M.D., Patricia A. Rogus, R.N., Hutzel Hospital, Wayne State University, Detroit, Michigan, USA, H.W. Michelmann, M.D., L. Mettler, M.D., Universitats Frauenklinik, Kiel, German Federal Republic, Jean Parinaud, Ph.D., Georges Pontonnier, M.D., Institut National de la Sante et de la Recherche Medicale, Toulouse, France, E. van Roosendaal, M.D., R. Schoysman, M.D., Academisch Zeikenhuis Vrije Universiteit, Brussels, Belgium, Melvin Taymor, M.D., Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts, USA, Raimund Winter, M.D., Geburtshilfliche Gynakologische Universitatsklinik Graz, Austria, Richard J. Worley, M.D., William R. Keye, Jr., M.D., University of Utah Medical Center, Salt Lake City, Utah, USA, John L. Yovich, M.D., University of Western Australia, Subiaco, Perth, Western Australia, Australia.†Supported by the Foundation for Reproductive Medicine, Inc., Chicago, Illinois.‡Presented in part in Future Aspects in Human In Vitro Fertilization Congress, Vienna, Austria, April 2 to 4, 1986, and the Forty-Second Annual Meeting of The American Fertility Society and the Eighteenth Annual Meeting of The Canadian Fertility and Andrology Society, Toronto, Canada, September 27 to October 2, 1986." Fertility and Sterility 46, no. 5 (November 1986): 897–902. http://dx.doi.org/10.1016/s0015-0282(16)49831-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Confino, Edmond, Richard H. Demir, Jan Friberg, and Norbert Gleicher. "The predictive value of hCG β subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: an international collaborative study**Supported by the Foundation for Reproductive Medicine, Inc., Chicago, Illinois.††The International Investigators in collaboration for this study were Benjamin G. Brackett, M.D., Ph.D., The University of Georgia College of Veterinary Medicine, Atlanta, Georgia; Jairo Garcia, M.D., Suheil Muasher, M.D., Anibal A. Acosta, M.D., Mason C. Andrews, M.D., Gary Hodgen, Ph.D., Zev Rosenwaks, M.D., Georgeanna Seegar Jones, M.D., and Howard W. Jones, Jr., M.D., Eastern Virginia Medical School, Norfolk, Virginia; Robert H. Glass, M.D., Mary C. Martin, M.D., and Pramila Dandekar, M.Sc., University of California, San Francisco, California; Vesselko Grizelj, M.D., Ph.D., University Medical School of Zagreb, Zagreb, Yugoslavia; George Henry, M.D., Jon Van Blerkom, M.D., and Barbara J. Corn, R.N., Reproductive Genetics, In Vitro, P.C., Denver, Colorado; Aarne Koskimies, M.D., and Markku Seppälä, M.D., Helsinki University Central Hospital, Helsinki, Finland; David Magyar, M.D., Robert J. Sokol, M.D., and Patricia A. Rogus, R.N., Hutzel Hospital, Wayne State University, Detroit, Michigan; H. W. Michelmann, M.D., and L. Mettler, M.D., Universitats Frauenklinik, Kiel, German Federal Republic; Jean Parinaud, Ph.D., and Georges Pontonnier, M.D., Institut National de la Santé et de la Recherche Médicale, Toulouse, France; E. van Roosendaal, M.D., and R. Schoysman, M.D., Academisch Ziekenhuis Vrije Universiteit, Brussels, Belgium; Melvin Taymor, M.D., Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts; Raimund Winter, M.D., Geburtshilflich-Gynakologische Universitatsklinik Graz, Graz, Austria; Richard J. Worley, M.D., and William R. Keye, Jr., M.D., University of Utah Medical Center, Salt Lake City, Utah; and John L. Yovich, F.R.A.C.O.G., University of Western Australia, Subiaco, Perth, Western Australia, Australia.‡‡Presented at The American College of Obstetricians and Gynecologists District VI Annual Meeting, September 25 to 28, 1985, Milwaukee, Wisconsin; the 41st Annual Meeting of The American Fertility Society, September 28 to October 2, 1985, Chicago, Illinois; and the 4th World Conference on In Vitro Fertilization, November 18 to 22, 1985, Melbourne, Victoria, Australia." Fertility and Sterility 45, no. 4 (April 1986): 526–31. http://dx.doi.org/10.1016/s0015-0282(16)49282-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Brennan, Mark, Justin Steil, Sophia Dyer, Laura Segal, James Salvia, and Erin Serino. "Policy-Relevant Indicators of Urban Emergency Medical Services COVID-19-Patient Encounters." Journal of Urban Health, November 2, 2022. http://dx.doi.org/10.1007/s11524-022-00672-0.

Full text

Abstract:

AbstractIn the first two years of the COVID-19 pandemic, members of Boston Emergency Medical Services, the City of Boston’s municipal ambulance service, had 7,689 encounters with confirmed-positive Boston residents. As COVID-19 virus strains continue to infect residents in Boston and across the country, understanding the correlation between population positivity, EMS encounters, and hospitalizations can inform healthcare response. This study examines urban virus-surveillance indicators that can serve as an early warning of the volume of Emergency Medical Services (EMS) encounters with COVID-19 positive patients and subsequently how EMS encounters with confirmed COVID-19 patients can serve as an early indicator of future hospital-demand surges. With daily data from Boston EMS and three other public agencies, we evaluate the relationship between five indicators and confirmed Boston EMS COVID-19 encounters by estimating separate Auto Regressive Integrated Moving Average models and cross-correlating their residuals. This study finds a significant and positive correlation between new COVID-19 cases citywide and EMS encounters 6 days later (p < 0.01), as well as between confirmed EMS encounters with COVID-19 patients and the number of intensive care unit beds occupied 7- and 18 -days later (p < 0.01). This study provides city health leadership needed clarity on the specific ordering and associated time lag in which infections in the population increase, EMS members encounter positive patients, and hospitals deliver care.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Boston City Hospital. Harvard Medical Unit"

1

Karnad, Anand B. Intrinsic factors: William Bosworth Castle and the development of hematology and clinical investigation at Boston City Hospital. Boston: Distributed by the Harvard University Press for the Francis A. Countway Library of Medicine, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dawson, David M., and Thomas D. Sabin. The cradle of American neurology: The Harvard Neurological Unit at the Boston City Hospital. Hollis, NH: Hollis Publishing, Inc., 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Harvard Medical Unit at Boston City Hospital. University of Virginia Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Karnad, Anand B. Intrinsic Factors: William Bosworth Castle and the Development of Hematology and Clinical Investigation at Boston City Hospital (Boston Medical Library in the Countway Library of Medicine). Boston Medical Library in the Countway Library of Medicine, Harvard Medical School, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

The Medical Elite Training For Leadership. Aldine, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Boston City Hospital. Harvard Medical Unit"

1

Miller, Stephen J. "The Harvard Unit at Boston City Hospital." In The Medical Elite, 35–55. Routledge, 2017. http://dx.doi.org/10.4324/9781315133089-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!